 |
|
| Blog results | Results 1 - 10 of about 11,321 for ovarian cancer recurrence. (0.45 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | Ovarian Cancer News Blog from medicineworld.org - http://medicineworld.org/news/ovariannews.html | |
| 13 Dec 2009 by Dr. NICK OBJECTIVES: To assess the clinical outcome of epithelial ovarian cancer patients who developed an apparently isolated lymph node recurrence after primary therapy. METHODS: The authors retrospectively assessed 69 patients with epithelial ... CANCER AND IMPORTANT MEDICAL NEWS - http://cancerology.blogspot.com/ |
| 28 Nov 2009 by NOVA West Island This is a global clinical trial involving the treatment of recurrent ovarian cancer. The 2 drugs involved are Carboplatin and Caelyx. These 2 drugs have been in use for many years and are safe with side effects that are manageable. ... Cancer Support Group - http://novacancersupport.blogspot.com/ |
| 11 Dec 2009 by admin After all, the AMA track record for ovarian cancer barely has a 50% survival rate. That doesn't include those that have an ovarian cancer recurrence, which is all but guaranteed if the original cause of the cancer is not addressed. ... Asbestos - http://www.blogcyclopedia.com/asbestos/ - References |
| 14 Dec 2009 by Digg RSS Search for cancer Rare cancer of the ovary is one of the most serious gynecological cancer. Nearly 3 in 4 women treated have their cancer recur … Faced with this terrible cancer, a new hope appeared: a vaccine to prevent recurrence and thus to better ... Cancer News Today - http://www.cancernewstoday.com/ |
| 11 Dec 2009 by a GenomeWeb staff reporter As an MD/PhD, Buckanovich is using his expertise in chemotherapy of ovarian cancer and endometrial cancer to study ovarian cancer consolidation and maintenance therapies in order to reduce ovarian cancer recurrences. ... GenomeWeb Daily News - http://www.genomeweb.com/newsletter/69886 [ More results from GenomeWeb Daily News ] |
| 16 Dec 2009 by Sai Because of the high recurrence rate in patients with advanced ovarian cancer, the issue of whether consolidation chemotherapy may improve time to progression and overall survival was examined in a phase III trial comparing 3 and 12 ... Ovarian Cancer 411.org - http://ovariancancer411.blogspot.com/ - References |
| 18 Dec 2009 "The renin-angiotensin pathway plays an important role in promoting cancer growth, explained Dr. Chae on December 11. The AT1 receptor is functionally expressed in several tumor types, including ovarian cancer. ... The Marshall Protocol Study Site - http://www.marshallprotocol.com/ |
| 1 Dec 2009 by Sandi Pniauskas ovarian+cancer. Technorati Blog Finder META name="y_key" content="4bf70d7d255e2449" OVARIAN CANCER and US - http://ovariancancerandus.blogspot.com/ |
| 17 Nov 2009 by LottieParker Claimed by guide LottieParker (via Special:CardAction) OrganizedWisdom Health - Recent changes [en] - http://organizedwisdom.com/Special:RecentChanges |
| 6 Dec 2009 by acountrydoctorwrites The real usefulness of this test is to follow an already advanced ovarian cancer for recurrence after treatment. Mark Michaud, like many other people, wishes antibiotics would work on viral infections, but they don't. ... A Country Doctor Writes: - http://acountrydoctorwrites.wordpress.com/ - References |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
